Abstract
Immune diseases have a strong genetic component with Mendelian patterns of inheritance. While the tight association has been a major understanding in the underlying pathophysiology for the category of immune diseases, the common features of these diseases remain unclear. Based on the potential commonality among immune genes, we design Gene Ranker for key gene identification. Gene Ranker is a network-based gene scoring algorithm that initially constructs a backbone network based on protein interactions. Patient gene expression networks are added into the network. An add-on process screens the networks of weighted gene co-expression network analysis (WGCNA) on the samples of immune patients. Gene Ranker is disease-specific; however, any WGCNA network that passes the screening procedure can be added on. With the constructed network, it employs the semi-supervised learning for gene scoring. The proposed method was applied to immune diseases. Based on the resulting scores, Gene Ranker identified potential key genes in immune diseases. In scoring validation, an average area under the receiver operating characteristic curve of 0.82 was achieved, which is a significant increase from the reference average of 0.76. Highly ranked genes were verified through retrieval and review of 27 million PubMed literatures. As a typical case, 20 potential key genes in rheumatoid arthritis were identified: 10 were de facto genes and the remaining were novel. Gene Ranker is available at http://www.alphaminers.net/GeneRanker/. Supplementary data are available at Bioinformatics online.
Highlights
The data were collected for 27 immune diseases
AUC is calculated for those unlabeled disease genes
Semi-Supervised Learning is transductive learning (Chapelle, et al, 2009; Zhu, 2006). This means both training samples and test samples are used in learning at the same time
Summary
2 DR.Noah Biotech, Gwanggyo Ace Tower1, 4 Daehak-ro, Yeongtong-gu, Suwon, South Korea. Appendix A: WGCNA networks for immune diseases Appendix B: Performance of Gene Ranker Appendix C: Validations for Immune Diseases [Appendix A] WGCNA networks for immune diseases
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.